(Q34546733)

2 August 2017

Parkinson's disease: the LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics (English)

1 reference

2 August 2017

1 reference

1

Vincenzo Bonifati

1 reference

2 August 2017

12 July 2006

1 reference

European Journal of Human Genetics

2 August 2017

1 reference

2 August 2017

14

1 reference

2 August 2017

1061-1062

1 reference

2 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ejhg.5201695

2 August 2017

0 references

cites work

LRRK2G2019S as a Cause of Parkinson's Disease in North African Arabs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

Clinical and positron emission tomography of Parkinson's disease caused by LRRK2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

Unraveling the pathogenesis of Parkinson's disease--the contribution of monogenic forms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

LRRK2 gene in Parkinson disease: Mutation analysis and case control association study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201695

7 January 2021

Identifiers

DOI

10.1038/SJ.EJHG.5201695

1 reference

PubMed ID

16835587

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

16835587